Inventor · disambiguated record
Jonathan M. Solomon
Also filed as: SOLOMON JONATHAN · SOLOMON JONATHAN M
7 granted patents·5 pending applications·17 citations·filing 2003–2024
79Inventor score
Files withNAPPER ANDREW3ARROWHEAD PHARMACEUTICALS INC2ELIXIR PHARMACEUTICALS INC2NAPPER ANDREW D2NOVARTIS AG2
Top patents by PatentIndex Score
12 records- 0181US8486990B2SirT inhibitors that bind to NADNAPPER ANDREW·Filed 2009·Granted Jul 16, 2013·10 cites·5 claims
- 0275US11999802B2Compositions and methods for selective protein degradationNOVARTIS AG·Filed 2018·Granted Jun 4, 2024·1 cites·33 claims
- 0375US9868949B2Organic compositions to treat EPAS1-related diseasesARROWHEAD RES CORPORATION·Filed 2014·Granted Jan 16, 2018·5 cites·20 claims
- 0473US10538765B2Organic compositions to treat EPAS1-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Jan 21, 2020·1 cites·19 claims
- 0571US2024384007A1Compositions and methods for selective protein degradationNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0667US11261444B2Organic compositions to treat EPAS1-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Mar 1, 2022·0 cites·17 claims
- 0754US7771961B2Cytochrome c acetylationELIXIR PHARMACEUTICALS INC·Filed 2009·Granted Aug 10, 2010·0 cites·31 claims
- 0852US2014163029A1SirT INHIBITORS THAT BIND TO NADNAPPER ANDREW D·Filed 2013·Application pending·0 cites
- 0948US2006074124A1Methods of treating a disorderNAPPER ANDREW·Filed 2005·Application pending·0 cites
- 1045US7575883B2Cytochrome c acetylationELIXIR PHARMACEUTICALS INC·Filed 2003·Granted Aug 18, 2009·0 cites·31 claims
- 1144US2016113903A1SirT INHIBITORS THAT BIND TO NADNAPPER ANDREW D·Filed 2015·Application pending·0 cites
- 1239US2005209300A1Methods of treating a disorderNAPPER ANDREW·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan M. Solomon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →